Opko Health Inc

NASDAQ:OPK   3:59:54 PM EDT
3.63
+0.06 (+1.54%)
5:24:54 PM EDT: $3.62 -0.01 (-0.14%)
Products

Opko Health To Develop And Commercialize Rayaldee® In Greater China With Nicoya Therapeutics

Published: 06/21/2021 12:30 GMT
Opko Health Inc (OPK) - Opko Health to Develop and Commercialize Rayaldee® in Greater China With Nicoya Therapeutics.
Opko Health Inc - Nicoya Will Make an Upfront Payment to Opko of $5 Million.
Opko Health - Additional $5 Million Payment Will Be Made by Nicoya During First 12 Months of Agreement Or Upon Nicoya Achieving a Certain Milestone.
Opko Health Inc - Opko Will Be Eligible to Receive Up to $115 Million Upon Achievement of Certain Development, Regulatory and Sales-based Milestones.
Opko Health Inc - Nicoya Will Also Pay Opko Tiered, Double-digit Royalties on Product Sales.